J Aboulker

4.9k total citations
91 papers, 1.8k citations indexed

About

J Aboulker is a scholar working on Virology, Infectious Diseases and Surgery. According to data from OpenAlex, J Aboulker has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Virology, 39 papers in Infectious Diseases and 20 papers in Surgery. Recurrent topics in J Aboulker's work include HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (33 papers) and HIV/AIDS Research and Interventions (25 papers). J Aboulker is often cited by papers focused on HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (33 papers) and HIV/AIDS Research and Interventions (25 papers). J Aboulker collaborates with scholars based in France, United Kingdom and United States. J Aboulker's co-authors include Vincent Meiffrédy, Philippe Flandre, Jean‐François Delfraissy, Patrick Yéni, Gilles Pialoux, Christine Durier, Corine Chazallon, Laurence Gérard, Anne‐Marie Taburet and Jean‐Michel Molina and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

J Aboulker

86 papers receiving 1.7k citations

Peers

J Aboulker
J Aboulker
Citations per year, relative to J Aboulker J Aboulker (= 1×) peers Alessandro Sinicco

Countries citing papers authored by J Aboulker

Since Specialization
Citations

This map shows the geographic impact of J Aboulker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Aboulker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Aboulker more than expected).

Fields of papers citing papers by J Aboulker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Aboulker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Aboulker. The network helps show where J Aboulker may publish in the future.

Co-authorship network of co-authors of J Aboulker

This figure shows the co-authorship network connecting the top 25 collaborators of J Aboulker. A scholar is included among the top collaborators of J Aboulker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Aboulker. J Aboulker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verdière, Nathalie, Christine Durier, Assia Samri, et al.. (2018). Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients. AIDS. 32(16). 2291–2299. 18 indexed citations
2.
Castro, Nathalie De, Joséphine Braun, Isabelle Charreau, et al.. (2016). Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial. AIDS Research and Therapy. 13(1). 17–17. 9 indexed citations
3.
Desaint, Corinne, Christine Durier, Jean‐Daniel Lelièvre, et al.. (2014). Update of the Long-term Follow-up of Healthy Volunteers from Preventive HIV-1 Vaccine Trials: ANRS COV1-COHVAC Cohort. AIDS Research and Human Retroviruses. 30(S1). A189–A190. 1 indexed citations
4.
Durier, Christine, Corinne Desaint, F. Lucht, et al.. (2012). Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults. AIDS. 27(1). 87–93. 20 indexed citations
5.
Gozalo, Claire, Laurence Gérard, Pascale Loiseau, et al.. (2011). Pharmacogenetics of Toxicity, Plasma Trough Concentration and Treatment Outcome with Nevirapine-Containing Regimen in Anti-Retroviral-Naïve HIV-Infected Adults: An Exploratory Study of the TRIANON ANRS 081 Trial. Basic & Clinical Pharmacology & Toxicology. 109(6). 513–520. 14 indexed citations
6.
Launay, Odile, Corinne Desaint, Christine Durier, et al.. (2011). Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial. The Journal of Infectious Diseases. 204(1). 124–134. 43 indexed citations
7.
Boulet, Thomas, Juliette Pavie, Isabelle Charreau, et al.. (2010). Impact on Health-Related Quality of Life of a Switch From Enfuvirtide to Raltegravir Among Multidrug-Resistant HIV-1–Infected Patients: A Randomized Open-Label Trial (EASIER-ANRS 138). HIV Clinical Trials. 11(5). 283–293. 8 indexed citations
8.
Delaugerre, Constance, Isabelle Charreau, Joséphine Braun, et al.. (2010). Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. AIDS. 24(15). 2391–2395. 24 indexed citations
9.
Bouldouyre, Marie‐Anne, Isabelle Charreau, B. Marchou, et al.. (2009). Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(5). 531–537. 11 indexed citations
10.
Goujard, Cécile, Fabienne Marcellin, Houria Hendel‐Chavez, et al.. (2007). Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study. AIDS Research and Human Retroviruses. 23(9). 1105–1113. 39 indexed citations
11.
Lévy, Yves, Christine Durier, Anne‐Sophie Lascaux, et al.. (2006). Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals. AIDS. 20(3). 405–413. 65 indexed citations
12.
Durier, Christine, Odile Launay, Vincent Meiffrédy, et al.. (2006). Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults. AIDS. 20(7). 1039–1049. 49 indexed citations
13.
Hoën, Bruno, Isabelle Fournier, Christine Lacabaratz, et al.. (2005). Structured Treatment Interruptions in Primary HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3). 307–316. 36 indexed citations
14.
Lévy, Yves, Christine Durier, Roman Krzysiek, et al.. (2003). Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection. AIDS. 17(3). 343–351. 82 indexed citations
15.
Salmon‐Céron, Dominique, Anne‐Marie Fillet, J Aboulker, et al.. (1999). Effect of a 14‐Day Course of Foscarnet on Cytomegalovirus (CMV) Blood Markers in a Randomized Study of Human Immunodeficiency Virus–Infected Patients with Persistent CMV Viremia. Clinical Infectious Diseases. 28(4). 901–905. 8 indexed citations
16.
Jardin, A, et al.. (1986). [Responsibility of the left renal vein and inferior vena cava in certain cases of myelitis and syringomyelia. Value of ligation of the venous reno-spinal trunk. Apropos of 30 cases].. PubMed. 20(2). 137–41. 4 indexed citations
17.
Redondo, A & J Aboulker. (1978). [Microsurgical treatment of cerebral ischemia].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 163–71.
18.
Garnier, H, et al.. (1977). [Surgery of the retro-hepatic and trans-diaphragmatic inferior vena cava in chronic spinal cord diseases of venous origin].. PubMed. 103(12). 1028–39. 2 indexed citations
19.
Aubin, Michèle, et al.. (1976). [Cavo-spinal phlebography in myelopathies of venous origin. Application of the method in 115 cases].. PubMed. 347. 403–13. 4 indexed citations
20.
Aboulker, J, et al.. (1961). [Obstruction of the foramina of Luschka and Magendie].. PubMed. 7. 210–27. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026